Author:
van der Vijgh Wim J. F.,Maessen Paul A.,Pinedo Herbert M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference18 articles.
1. Arcamone F, Lazatti M, Vicario GP, Zini G (1984) Disposition of14C-labelled 4’-epidoxorubicin and doxorubicin in the rat: a comparative study. Cancer Chemother Pharmacol 12: 157–166
2. Bertazolli C, Rovero C, Ballerini L, Lux B, Balconi F, Antongiovanni V, Magrini U (1985) Experimental systemic toxicology of 4’-epidoxorubicin, a new less cardiotoxic anthracycline antitumor agent. Toxicol Appl Pharmacol 79: 412–422
3. Broggini M, Colombo T, Martini A, Donelli MG (1980) Studies on the comparative distribution and biliary excretion of doxorubicin and 4’-epidoxorubicin in mice and rats. Cancer Treat Rep 64: 897–904
4. Cummings J, Merry S, Willmot N (1986) Disposition kinetics of Adriamycin, Adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma. Eur J Cancer Clin Oncol 22: 451–460
5. Danesi R, Del Tacca M, Torre P, Bernardini C (1986) General and cardiac toxicity of Adriamycinol in rats. Anticancer Res 6: 967–972
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献